In general, except for a significantly lower disease control rate (DCR) in HBV-infected HCC patients, the objective response rate (ORR) of anti-PD-1/PD-L1 did not differ significantly between virus-positive and virus-negative patients (180). This evidence concerns the gene PDCD1 and hepatocellular carcinoma.